Biaryl compounds as serine protease inhibitors

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 229/38 (2006.01) A61K 31/155 (2006.01) A61K 31/192 (2006.01) A61K 31/24 (2006.01) A61K 31/255 (2006.01) A61K 31/27 (2006.01) A61K 31/34 (2006.01) A61K 31/341 (2006.01) A61K 31/38 (2006.01) A61K 31/381 (2006.01) A61K 31/40 (2006.01) A61K 31/415 (2006.01) A61K 31/425 (2006.01) A61K 31/426 (2006.01) A61K 31/44 (2006.01) A61K 31/4418 (2006.01) A61K 31/495 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) A61K 31/55 (2006.01) A61K 31/69 (2006.01) C07C 63/04 (2006.01) C07C 233/54 (2006.01) C07C 235/84 (2

Patent

CA 2426430

Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating agents.

La présente invention concerne des composés représentés par la formule (I) qui conviennent comme inhibiteurs de trypsine comme les enzymes sérine protéases telles que la thrombine, le facteur VIIa, le facteur Xa, TF/FVIIa et la trypsine. Ces composés peuvent convenir pour traiter et/ou pour prévenir des troubles de la coagulation, et comme agents anticoagulants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biaryl compounds as serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biaryl compounds as serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaryl compounds as serine protease inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2054545

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.